Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Zech

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|October 11, 1990
Apolipoprotein A-I metabolism in subjects with a PstI restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemiaP Roma, R E Gregg, C Bishop, et al.
The Journal of Clinical Investigation|March 1, 1995
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansD J Rader, W A Mann, W Cain, et al.
The Journal of Clinical Investigation|April 15, 1996
Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent mannerM E Brousseau, S Santamarina-Fojo, L A Zech, et al.
The American Journal of Cardiology|July 1, 1984
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patientsD L Sprecher, E J Schaefer, K M Kent, et al.
The Journal of Clinical Investigation|March 1, 1981
Transport of apolipoproteins A-I and A-II by human thoracic duct lymphD W Anderson, E J Schaefer, T J Bronzert, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemiaH H Schmidt, M Stuhrmann, R Shamburek, et al.
Journal of Lipid Research|July 1, 1995
Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humansW R Fisher, V Venkatakrishnan, L A Zech, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|October 11, 1990
Apolipoprotein A-I metabolism in subjects with a PstI restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemiaP Roma, R E Gregg, C Bishop, et al.
The Journal of Clinical Investigation|March 1, 1995
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansD J Rader, W A Mann, W Cain, et al.
The Journal of Clinical Investigation|April 15, 1996
Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent mannerM E Brousseau, S Santamarina-Fojo, L A Zech, et al.
The American Journal of Cardiology|July 1, 1984
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patientsD L Sprecher, E J Schaefer, K M Kent, et al.
The Journal of Clinical Investigation|March 1, 1981
Transport of apolipoproteins A-I and A-II by human thoracic duct lymphD W Anderson, E J Schaefer, T J Bronzert, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemiaH H Schmidt, M Stuhrmann, R Shamburek, et al.
Journal of Lipid Research|July 1, 1995
Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humansW R Fisher, V Venkatakrishnan, L A Zech, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Pageof 10